Chronic Pain Relief: An Overview
Everyone will experience pain at some point in their lives. Pain is a necessary form of protection against injuries, diseases, or conditions that would otherwise impair or even kill us. Pain alerts us that something is wrong. Pain can be either ‘acute’ or ‘chronic’ – the distinguishing characteristic between the two is their duration.
Acute pain usually occurs after a specific injury. It appears quickly and is usually very intense – one example is the pain of a broken bone. It subsides fairl Read More...
Pregnancy and Drug Detox
One main question a pregnant woman who is addicted, or the pregnant woman's family may have, is "is it possible for a pregnant woman to go through detox?" There are many factors that can contribute to the answer of this question, which is yes and no. Pregnancy can be unpredictable without drug addiction, so, it would be hard to answer either way without considering things about pregnant women and detox.
The first thing to think about when wondering about pregnant women and detox, is that the u Read More...
Drug Detox for Prescription Painkillers Again? When Will We Learn Our Lesson?
It seems that people are finally getting the point about methadone being a very dangerous drug. Although it's been prescribed as a painkiller for decades, prescriptions have increased by 715 percent in the last few years - and an increase in methadone-related deaths and the number of people needing drug detox and drug rehab for addiction have followed.
Why the sudden increase in methadone prescriptions? When Purdue Pharma developed OxyContin, they were allegedly filling a need - OxyContin was s Read More...
Takeda, SPI announce that lubiprostone phase 3 trial on OBD meets primary endpoint Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone. Read More...
Press Release Sucampo Pharmaceuticals Inc. Posted on:02 Feb 12 Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone. Read More...
Court Documents Reveal Judges Alleged Methadone Abuse Butte justice of the peace, Bob Lee, is facing 34 felony charges out of two counties. NBC Montana went through the charging affidavit to get a better understanding of how much methadone prosecutors claim Lee was using illegally. Read More...